Individualized ranibizumab therapy strategies in year 3 after as-needed treatment for polypoidal choroidal vasculopathy

被引：0
|
作者：
Taiichi Hikichi
机构：
[1] Ohtsuka Eye Hospital,
来源：
BMC Ophthalmology | / 15卷
关键词：
Individualized therapy; Polypoidal choroidal vasculopathy; Ranibizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Individualized ranibizumab therapy strategies in year 3 after as-needed treatment for polypoidal choroidal vasculopathy
    Hikichi, Taiichi
    BMC OPHTHALMOLOGY, 2015, 15
  • [2] INDIVIDUALIZED RANIBIZUMAB MONOTHERAPY STRATEGIES DURING 3 AFTER AS-NEEDED TREATMENT BASED ON MONTHLY EXAMINATIONS FOR POLYPOIDAL CHOROIDAL VASCULOPATHY
    Hikichi, Taiichi
    Kitamei, Hirokuni
    Shioya, Shoko
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [3] Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathy
    Hikichi, Taiichi
    Higuchi, Makoto
    Matsushita, Takuro
    Kosaka, Shoko
    Matsushita, Reiko
    Takami, Kimitaka
    Ohtsuka, Hideo
    Kitamei, Hirokuni
    Shioya, Shoko
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (05) : 617 - 621
  • [4] FACTORS PREDICTIVE OF OUTCOMES 1 YEAR AFTER 3 MONTHLY RANIBIZUMAB INJECTIONS AND AS-NEEDED REINJECTIONS FOR POLYPOIDAL CHOROIDAL VASCULOPATHY IN JAPANESE PATIENTS
    Hikichi, Taiichi
    Higuchi, Makoto
    Matsushita, Takuro
    Kosaka, Shoko
    Matsushita, Reiko
    Takami, Kimitaka
    Ohtsuka, Hideo
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (09): : 1949 - 1958
  • [5] PHOTODYNAMIC THERAPY, RANIBIZUMAB, AND RANIBIZUMAB WITH PHOTODYNAMIC THERAPY FOR THE TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY
    Rouvas, Alexandros A.
    Papakostas, Thanos D.
    Ntouraki, Amalia
    Douvali, Maria
    Vergados, Ioannis
    Ladas, Ioannis D.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2011, 31 (03): : 464 - 474
  • [6] One-Year Results of Three Monthly Ranibizumab Injections and As-Needed Reinjections for Polypoidal Choroidal Vasculopathy in Japanese Patients
    Hikichi, Taiichi
    Higuchi, Makoto
    Matsushita, Takuro
    Kosaka, Shoko
    Matsushita, Reiko
    Takami, Kimitaka
    Ohtsuka, Hideo
    Ariga, Hiroko
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 154 (01) : 117 - 124
  • [7] Comparison of one-year outcomes between as-needed brolucizumab and aflibercept for polypoidal choroidal vasculopathy
    Fukuda, Yoshiko
    Sakurada, Yoichi
    Matsubara, Mio
    Kotoda, Yumi
    Kasai, Yuka
    Sugiyama, Atsushi
    Kashiwagi, Kenji
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2023, 67 (04) : 402 - 409
  • [8] Comparison of one-year outcomes between as-needed brolucizumab and aflibercept for polypoidal choroidal vasculopathy
    Yoshiko Fukuda
    Yoichi Sakurada
    Mio Matsubara
    Yumi Kotoda
    Yuka Kasai
    Atsushi Sugiyama
    Kenji Kashiwagi
    Japanese Journal of Ophthalmology, 2023, 67 : 402 - 409
  • [9] Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy
    Kikushima, Wataru
    Sakurada, Yoichi
    Sugiyama, Atsushi
    Yoneyama, Seigo
    Tanabe, Naohiko
    Matsubara, Mio
    Mabuchi, Fumihiko
    Iijima, Hiroyuki
    SCIENTIFIC REPORTS, 2017, 7
  • [10] Treatment results at 1 year of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good visual acuity
    Mori, Ryusaburo
    Yuzawa, Mitsuko
    Akaza, Eriko
    Haruyama, Miho
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2013, 57 (04) : 365 - 371
12345